Blueprint Medicines Corporation (BPMC)
NASDAQ: BPMC · Real-Time Price · USD
87.66
+1.57 (1.82%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Blueprint Medicines Employees
Blueprint Medicines had 649 employees as of December 31, 2024. The number of employees decreased by 6 or -0.92% compared to the previous year.
Employees
649
Change (1Y)
-6
Growth (1Y)
-0.92%
Revenue / Employee
$784,012
Profits / Employee
-$103,373
Market Cap
5.60B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 649 | -6 | -0.92% |
Dec 31, 2023 | 655 | 14 | 2.18% |
Dec 31, 2022 | 641 | 146 | 29.49% |
Dec 31, 2021 | 495 | 66 | 15.38% |
Dec 31, 2020 | 429 | 46 | 12.01% |
Dec 31, 2019 | 383 | 166 | 76.50% |
Dec 31, 2018 | 217 | 68 | 45.64% |
Dec 31, 2017 | 149 | 43 | 40.57% |
Dec 31, 2016 | 106 | 25 | 30.86% |
Dec 31, 2015 | 81 | 20 | 32.79% |
Dec 31, 2014 | 61 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
BPMC News
- 2 days ago - Blueprint Medicines to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025 - PRNewsWire
- 21 days ago - Blueprint Medicines Continues Targeting Mast Cells For Potential Billion-Dollar Growth - Seeking Alpha
- 27 days ago - Blueprint Medicines to Present at 24th Annual Needham Virtual Healthcare Conference - PRNewsWire
- 2 months ago - Blueprint Medicines Highlights Leading Portfolio of Mast Cell-Targeted Therapies at 2025 AAAAI / WAO Joint Congress - PRNewsWire
- 2 months ago - Blueprint Medicines Corporation (BPMC) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Blueprint Medicines Reports Fourth Quarter and Full Year 2024 Results - PRNewsWire
- 2 months ago - Blueprint Medicines to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 13, 2025 - PRNewsWire
- 3 months ago - Blueprint Medicines Provides 2025 Outlook and Highlights Strategy for Continued Growth - PRNewsWire